Does early discontinuation of topical 4% 5-fluorouracil affect lesion clearance for actinic keratosis? Results from a dose-ranging study

J Eur Acad Dermatol Venereol. 2024 Nov 22. doi: 10.1111/jdv.20441. Online ahead of print.

Authors

Markus V Heppt^{1

2}, Claas Ulrich^{3

4}

Affiliations

¹ Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
² Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CC ER-EMN), Erlangen, Germany.
³ Collegium Medicum GmbH, Berlin, Germany.
⁴ Charité - Universitätsmedizin Berlin, Institut für Allergieforschung IFA & Fraunhofer Standort Immunologie und Allergologie IA, Berlin, Germany.

PMID: 39575853
DOI: 10.1111/jdv.20441

No abstract available

Publication types

Letter